Heping Xu
个人简介
教育背景
暂无内容
工作经历
2024.01 – 至今
Frontiers in Ophthalmology
Specialty Editor-in-Chief for Inflammatory Eye Disease Section
2023.01 – 至今
National Autonomous University of Mexico (墨西哥国立自治大学), Mexico
Honorary Lecturer
2021.01 – 至今
National University of Rosario (阿根廷罗萨里奥国立大学), Argentina
Honorary Lecturer
2021.01 – 至今
Peking University-Hong Kong Science & Technology University Joint Medical Research Centre of Shenzhen, China
Honorary Professor
2021.01 – 至今
Tianjin Medical University, China
Honorary Professor
2021.01 – 2024.12
Frontiers in Ophthalmology
Associate Editor
2021.01 – 至今
Biomedicines
Editorial Board Member
2021.01 – 至今
Journal of Ocular Pharmacology and Therapeutics (JOPT)
Editorial Board member
2018.01 – 至今
Current Molecular Pharmacology
Editorial Board Member
2018.01 – 至今
Current Eye Research
Editorial Board Member
2018.01 – 至今
Annals of Translational Medicine
Editorial Board Member
2017.01 – 至今
Experimental Eye Research
Executive Editor
2016.01 – 至今
University of Cologne (科隆大学, 德国)
Visiting Scientist
2016.01 – 至今
Annals of Eye Science
Editorial Board Member
2014.01 – 2021.12
Scientific Reports
Editorial Board Member
荣誉奖项
- Honorary Lecturer(2023)|National Autonomous University of Mexico (墨西哥国立自治大学), Mexico
- Honorary Lecturer(2021)|National University of Rosario (阿根廷罗萨里奥国立大学), Argentina
- Honorary Professor(2021)|Peking University-Hong Kong Science & Technology University Joint Medical Research Centre of Shenzhen, China
- Fellow (Silver) of the Association for Research in Vision & Ophthalmology (FARVO)(2021)|Association for Research in Vision & Ophthalmology
- Fellow of the Association for Ocular Pharmacology and Therapeutics (FAOPT)(2021)|Association for Ocular Pharmacology and Therapeutics
- Visiting Scientist(2016)|University of Cologne (科隆大学, 德国)
- Cora Verhagen award(2018)
- The Experimental Uveitis Research Award (2nd prize, for the study of Complement in Uveitis)(2011)|European Uveitis Patients Association (欧洲葡萄膜炎患者协会)
- The Experimental Uveitis Research Award (3rd prize, for the study of BRB in Uveitis)(2011)|European Uveitis Patients Association (欧洲葡萄膜炎患者协会)
- European Frontiers in Ocular Pharmacology Lecture (4th Series)(2008)|Italian Society of Pharmacology (意大利药学会)
- The Experimental Uveitis Research Award (1st prize, for the study of leukocyte trafficking in Uveitis)(2005)|German Uveitis Patient Interest Group (德国葡萄膜炎患者联合会)
- Research Council UK (RCUK) Fellowship Award(2005)|Research Council UK (RCUK)
视网膜损伤与修复过程中NK1.1⁺细胞的双相性与时间依赖性作用
整合素介导的 focal adhesion 在 subretinal fibrosis 中的巨噬细胞-肌成纤维细胞转化中起关键作用
RPE特异性Lrp2缺陷小鼠中视神经元的特异性丧失和神经血管支持受损构成了近视视网膜病变的基础
黄斑纤维化继发于新生血管性年龄相关性黄斑变性:从临床到生物学
在正常条件下,微生物组存在于神经视网膜和脉络膜中,并能对视网膜损伤做出快速反应。
长期低剂量阿司匹林通过抑制TSP-1表达促进激光诱导的脉络膜新生血管形成
LRG1在病理性纤维化中的关键作用
人髓细胞和偏幼粒细胞期中性粒细胞抑制肿瘤免疫并促进癌症进展
衰老改变了抗菌肽的表达并诱导视网膜色素上皮细胞产生β-淀粉样蛋白
补体C3/C3aR信号通路抑制可改善实验性视网膜静脉阻塞的视网膜损伤
吸烟通过Sema4D-PlexinB1轴介导的周细胞激活加剧新生血管性年龄相关性黄斑变性。
基于泛组学的来自暴发真菌物种复合体的高度多药适应菌株的表征和预测

